Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox and Kowa Sign Key Agreement worth up to €191.5 million for Exclusive Rights to Glaucoma Treatment NCX 470 in U.S. and all Unlicensed Territories

July 17, 2025

View Press Release Corporate presentation Contact us
Previous